New Journey Health Technology GroupLTD Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 1/6
New Journey Health Technology GroupLTD has been growing earnings at an average annual rate of 74.9%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 2.1% per year. New Journey Health Technology GroupLTD's return on equity is 2.5%, and it has net margins of 1.3%.
Anahtar bilgiler
74.9%
Kazanç büyüme oranı
76.4%
EPS büyüme oranı
Healthcare Sektör Büyümesi | 7.0% |
Gelir büyüme oranı | 2.1% |
Özkaynak getirisi | 2.5% |
Net Marj | 1.3% |
Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Some May Be Optimistic About New Journey Health Technology GroupLTD's (SZSE:002219) Earnings
Nov 04New Journey Health Technology Group Co.,LTD (SZSE:002219) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Oct 25Is New Journey Health Technology GroupLTD (SZSE:002219) Using Too Much Debt?
Oct 18Returns On Capital Are Showing Encouraging Signs At New Journey Health Technology GroupLTD (SZSE:002219)
Sep 30Pinning Down New Journey Health Technology Group Co.,LTD's (SZSE:002219) P/S Is Difficult Right Now
Sep 10New Journey Health Technology GroupLTD (SZSE:002219) Has A Somewhat Strained Balance Sheet
Jun 24Returns At New Journey Health Technology GroupLTD (SZSE:002219) Are On The Way Up
Jun 07What New Journey Health Technology Group Co.,LTD's (SZSE:002219) P/S Is Not Telling You
May 14New Journey Health Technology GroupLTD's (SZSE:002219) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 24Gelir ve Gider Dağılımı
New Journey Health Technology GroupLTD nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Sep 24 | 3,764 | 50 | 823 | 28 |
30 Jun 24 | 3,788 | 34 | 845 | 33 |
31 Mar 24 | 3,668 | 33 | 859 | 31 |
31 Dec 23 | 3,590 | 31 | 862 | 28 |
30 Sep 23 | 3,336 | 77 | 928 | 7 |
30 Jun 23 | 3,262 | 163 | 859 | 1 |
31 Mar 23 | 3,185 | 177 | 787 | 0 |
01 Jan 23 | 3,161 | 156 | 744 | 0 |
30 Sep 22 | 3,124 | -200 | 782 | 0 |
30 Jun 22 | 3,058 | -272 | 802 | 0 |
31 Mar 22 | 3,079 | -323 | 811 | 0 |
01 Jan 22 | 3,016 | -371 | 822 | 0 |
30 Sep 21 | 3,022 | -62 | 700 | -1 |
30 Jun 21 | 3,029 | -54 | 663 | -1 |
31 Mar 21 | 2,954 | -68 | 649 | 0 |
31 Dec 20 | 2,806 | -52 | 597 | 0 |
30 Sep 20 | 2,953 | -2,399 | 1,649 | 2 |
30 Jun 20 | 3,088 | -2,506 | 1,695 | 3 |
31 Mar 20 | 3,302 | -2,577 | 1,680 | 1 |
31 Dec 19 | 3,684 | -2,520 | 1,798 | 1 |
30 Sep 19 | 3,806 | -1,201 | 1,057 | 9 |
30 Jun 19 | 3,829 | -1,551 | 1,120 | 8 |
31 Mar 19 | 3,829 | -1,442 | 1,110 | 9 |
31 Dec 18 | 3,838 | -1,418 | 1,107 | 8 |
30 Sep 18 | 4,168 | -436 | 905 | 0 |
30 Jun 18 | 4,152 | 110 | 772 | 0 |
31 Mar 18 | 3,853 | 182 | 733 | 0 |
31 Dec 17 | 3,399 | 203 | 594 | 0 |
30 Sep 17 | 2,966 | 454 | 413 | 0 |
30 Jun 17 | 2,511 | 425 | 362 | 0 |
31 Mar 17 | 2,288 | 403 | 350 | 0 |
31 Dec 16 | 2,175 | 404 | 327 | 0 |
30 Sep 16 | 1,637 | 335 | 265 | 0 |
30 Jun 16 | 1,532 | 386 | 227 | 0 |
31 Mar 16 | 1,386 | 343 | 205 | 0 |
31 Dec 15 | 1,182 | 324 | 172 | 0 |
30 Sep 15 | 905 | 229 | 138 | 0 |
30 Jun 15 | 744 | 179 | 111 | 0 |
31 Mar 15 | 681 | 236 | 100 | 0 |
31 Dec 14 | 686 | 257 | 95 | 0 |
30 Sep 14 | 679 | 251 | 96 | 0 |
30 Jun 14 | 617 | 225 | 128 | 0 |
31 Mar 14 | 574 | 194 | 141 | 0 |
31 Dec 13 | 565 | 170 | 173 | 0 |
Kaliteli Kazançlar: 002219 has a large one-off loss of CN¥28.8M impacting its last 12 months of financial results to 30th September, 2024.
Büyüyen Kar Marjı: 002219's current net profit margins (1.3%) are lower than last year (2.3%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 002219 has become profitable over the past 5 years, growing earnings by 74.9% per year.
Büyüme Hızlandırma: 002219's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: 002219 had negative earnings growth (-34.8%) over the past year, making it difficult to compare to the Healthcare industry average (-5.7%).
Özkaynak Getirisi
Yüksek ROE: 002219's Return on Equity (2.5%) is considered low.